Back to the main directory
Industry / Sector Analysis / Equity
- Spin off into three publicly traded companies by La Française
- Q3 2021 by La Française
- BILI: User Engagement And Interaction Levels Continue To Go Higher With More Content; Positive on 3Q21 Performance by T.H. Capital
- MOSL: ECOSCOPE: Where do unlisted corporate profits come from? by Motilal Oswal
- MOSL: AUROBINDO PHARMA (Buy)-Channel destocking, higher RM costs impact margins by Motilal Oswal
- MOSL: INDRAPRASTHA GAS (Neutral)-Rewarding 2QFY22, although risk-reward unfavorable by Motilal Oswal
- MOSL: BHEL (Sell)-Operating losses continue as the recovery prolongs by Motilal Oswal
- MOSL: Morning India (10/November/21): 1. Angel One - Initiating Coverage (Leaner, stronger, faster – A transformed broker!); 2. India Strategy (The Eagel Eye); 3. Mahindra & Mahindra; 4. Britannia Ind.; 5. Bosc by Motilal Oswal
- Nochmals deutliche Anhebung der Guidance – Buy by Sphene Capital GmbH
- Q3 2021 by La Française
- (Adidas): 3Q21 by La Française
- Analyst Pin-board BFC – Hard to maintain the gross margin amid the rally in fertilizer prices by Viet Dragon Securities
- Hearing Aid sector deep dive by La Française
- $QQQ ETF Elliott Wave & Long Term Cycles by Elliott Forecast
- Elliott Wave View: Oil (CL) Looking for 3 Waves Rally by Elliott Forecast
- Q3 2021 by La Française
- Q3 2021 by La Française
- Analyst Pin-board PNJ – Takeaways from Q3 2021 AM by Viet Dragon Securities
- PHARMAGEST - CA T3 : Effet de base défavorable hormis pour la e-Santé - Achat - Obj. 143,2 € vs 138,7 € - Pot. +40% by GreenSome Finance
- Q3 2021 by La Française
- Raiffeisen - Strong consensus beat, en route to a record year by Concorde Securities
- BRD - In line Q3, dividend matters most by Concorde Securities
- MOL - Again strong earnings, guidance lift, yet no update on special dividend by Concorde Securities
- Research Comment - CENIT AG - 11.11.21 by GBC AG
- Waberers - Another profitable quarter despite increasing risks by Concorde Securities